ABOUT
Our Company
Our Technology
Sales
Gentian Diagnostics AB
Gentian USA. Inc.
Careers
PRODUCTS
GCAL® Calprotectin
Cystatin C
NT-proBNP Pre-Launch
SARS-CoV-2 Ab Pre-Launch
Canine CRP
IFU Documents
INSIGHTS
INVESTORS
Key information
Share information
Reports & presentations
Financial calendar
Corporate governance
Investor news
IR contact
NEWS
CONTACT
Menu
ABOUT
Our company
Our Technology
Sales
Gentian Diagnostics AB
Gentian USA. Inc.
Careers
PRODUCTS
GCAL® Calprotectin
Cystatin C
NT-proBNP Pre-launch
SARS-CoV-2 Ab Pre-Launch
Canine CRP
IFU Documents
INSIGHTS
INVESTORS
Key information
Share information
Reports & presentations
Financial calendar
Corporate governance
Investor News
IR contact
NEWS
CONTACT
SEARCH
reports and presentations
We innovate diagnostic efficiency
Reports and presentations
Reports
Presentations
Reports 2021
11th Feb 2021 - Quarterly Report - Q4
16th Apr 2021 - Quarterly Report - Q1
25th Aug 2021 - Half-Yearly Report
21st Oct 2021 - Quarterly Report - Q3
Annual reports
2020 - Annual Report
2019 - Annual Report
2018 - Annual Report
Financial presentations
11th Feb 2021 - Quarterly Presentation - Q4
16th Apr 2021 - Quarterly Presentation - Q1
25th Aug 2021 - Half-Yearly Presentation
2
1st Oct 2021 - Quarterly Presentation - Q3
Company presentation June 2021
Other presentations
2021
DNB Markets Interview with CEO Hilja Ibert
2020
DNB Nordic Healthcare Conference
Pareto Healthcare conference
2019
DNB Nordic American Life Science conference
IR Contact
Njaal Kind
CFO, Gentian Diagnostics ASA
njaal.kind@gentian.com
+47 91906525